Scope of the Report
The report entitled “The US Knee Implant Market: Size, Trends & Forecasts (2018-2022)”, provides a detailed analysis of the US knee implant market with market sizing and growth pattern. The analysis includes knee implant market in terms of value, market share by products and materials. It also includes analysis of knee implant market in terms of products with their actual and forecasted market size.

Furthermore, the report also assesses the key opportunities available in the market and summarizes the dynamic forces that are and will be accountable for growth of the industry. Growth of the US knee implant market has also been forecasted for the period 2018-2022, taking into consideration previous growth outlines, growth drivers and the existing and forthcoming trends.

The US knee implant market is dominated by four major players namely Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson (DePuy Synthes), and Smith and Nephew whose company profiling has been done in the report. This segment of the report summarizes business overview, financial overview and the business strategies adopted by respective companies.

Company Coverage

  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson (DePuy Synthes)
  • Smith & Nephew

Executive Summary
Reconstructive joint replacements include knee replacement implants, hip replacement implants and extremities. In knee replacement surgery, damaged knees are resurfaced with artificial components, and these are known as knee implants. A wide number of implants are available today that are used in knee replacement surgeries. Three types of knee implants are widely used by surgeons: single radius knee, fixed bearing and mobile bearing.

The US knee implant market has shown upward trends over the past few years and is anticipated that it would follow the same trend over the forecasted period also i.e. 2018-2022 with a significant growth rate on the back of growing elderly population in the region.

The growth in the market will primarily be driven by growing chronic rheumatic conditions, rising prevalence of obesity, rising healthcare spending, technological advancements, etc. Yet the growth of market is obstructed by some factors such as stringent medical regulations, product recalls by FDA and rising awareness of non-surgical alternatives.